Lonza has acquired Micro-Macinazione, one of Europe’s leading contract manufacturers providing micronization of active ingredients for the pharmaceutical and fine chemical industries. Micro- Macinazione, which had sales of ~ CHF 20 million in 2016, has 120 employees and is based in Monteggio, Switzerland. Micro-Macinazione was purchased from Cross and the acquisition was completed on 26th July 2017. Financial details of the deal were not disclosed.
The acquisition of Micro-Macinazione creates the global leader in the field of micronization services by building on Lonza/Capsugel’s existing micronization clinical and commercial manufacturing capabilities that are based in Quakertown, PA (USA). Lonza/Capsugel strengthened its micronization offering to customers in January 2016 when it acquired Powdersize and has since invested in significant additional capacity at this site which came on stream in early 2017.